Cas no 850162-87-7 (methyl 3-phenylpyridine-4-carboxylate)

Methyl 3-phenylpyridine-4-carboxylate is a versatile heterocyclic compound featuring a pyridine core substituted with a phenyl group at the 3-position and a methyl ester at the 4-position. This structure imparts reactivity suitable for further functionalization, making it valuable in pharmaceutical and agrochemical synthesis. The ester group offers a handle for hydrolysis or transesterification, while the phenyl-pyridine scaffold contributes to its potential as a building block for bioactive molecules. Its stability under standard conditions and compatibility with common organic solvents enhance its utility in multistep synthetic routes. The compound is particularly relevant in the development of ligands, catalysts, and intermediates for medicinal chemistry applications.
methyl 3-phenylpyridine-4-carboxylate structure
850162-87-7 structure
Product Name:methyl 3-phenylpyridine-4-carboxylate
CAS No:850162-87-7
MF:C13H11NO2
MW:213.231943368912
MDL:MFCD13181727
CID:2759948
PubChem ID:53485350
Update Time:2025-10-28

methyl 3-phenylpyridine-4-carboxylate Chemical and Physical Properties

Names and Identifiers

    • methyl 3-phenylpyridine-4-carboxylate
    • 3-Phenylpyridine-4-carboxylic acid methyl ester
    • phenyl-3 carbomethoxy-4 pyridine
    • Methyl 3-phenyl-4-pyridinecarboxylate (ACI)
    • Methyl 3-Phenylisonicotinate
    • 850162-87-7
    • DTXSID80704534
    • Methyl3-Phenylisonicotinate
    • CS-0458959
    • SY040050
    • MFCD13181727
    • AC6933
    • DB-082859
    • MDL: MFCD13181727
    • Inchi: 1S/C13H11NO2/c1-16-13(15)11-7-8-14-9-12(11)10-5-3-2-4-6-10/h2-9H,1H3
    • InChI Key: KYTMHPFNGAMHPC-UHFFFAOYSA-N
    • SMILES: O=C(C1C(C2C=CC=CC=2)=CN=CC=1)OC

Computed Properties

  • Exact Mass: 213.07900
  • Monoisotopic Mass: 213.078978594g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 0
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 16
  • Rotatable Bond Count: 3
  • Complexity: 236
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 2.3
  • Topological Polar Surface Area: 39.2?2

Experimental Properties

  • PSA: 39.19000
  • LogP: 2.53520

methyl 3-phenylpyridine-4-carboxylate Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Chemenu
CM178961-5g
methyl 3-phenylisonicotinate
850162-87-7 97%
5g
$439 2021-08-05
SHANG HAI HAO HONG Biomedical Technology Co., Ltd.
1529626-5g
Methyl 3-phenylisonicotinate
850162-87-7 98%
5g
¥8100.00 2024-07-28
Chemenu
CM178961-1g
methyl 3-phenylisonicotinate
850162-87-7 97%
1g
$173 2022-06-10
Chemenu
CM178961-5g
methyl 3-phenylisonicotinate
850162-87-7 97%
5g
$517 2022-06-10
Crysdot LLC
CD11046489-5g
Methyl 3-phenylisonicotinate
850162-87-7 97%
5g
$465 2024-07-18
eNovation Chemicals LLC
D776349-5g
Methyl 3-Phenylisonicotinate
850162-87-7 95%
5g
$825 2025-02-20
Ambeed
A175885-1g
Methyl 3-phenylisonicotinate
850162-87-7 97%
1g
$445.0 2025-04-16
Ambeed
A175885-5g
Methyl 3-phenylisonicotinate
850162-87-7 97%
5g
$1335.0 2025-04-16
eNovation Chemicals LLC
D776349-5g
Methyl 3-Phenylisonicotinate
850162-87-7 95%
5g
$825 2025-02-26
eNovation Chemicals LLC
D776349-5g
Methyl 3-Phenylisonicotinate
850162-87-7 95%
5g
$825 2024-07-20

methyl 3-phenylpyridine-4-carboxylate Production Method

Production Method 1

Reaction Conditions
1.1 Reagents: Potassium carbonate Catalysts: Tetrakis(triphenylphosphine)palladium Solvents: Toluene ;  rt → reflux; 4 h, reflux; reflux → rt
Reference
9-Hydroxyazafluorenes and Their Use in Thrombin Inhibitors
Stauffer, Kenneth J.; et al, Journal of Medicinal Chemistry, 2005, 48(7), 2282-2293

Production Method 2

Reaction Conditions
1.1 Reagents: Trifluoroacetic acid ,  Potassium persulfate Catalysts: Ferric nitrate Solvents: Water ,  Trifluorotoluene ;  10 min, rt
1.2 24 h, 50 °C
Reference
Iron-catalyzed direct C-H arylation of heterocycles and quinones with arylboronic acids
Deb, Arghya; et al, European Journal of Organic Chemistry, 2013, 2013(24), 5251-5256

methyl 3-phenylpyridine-4-carboxylate Raw materials

methyl 3-phenylpyridine-4-carboxylate Preparation Products

Additional information on methyl 3-phenylpyridine-4-carboxylate

Comprehensive Overview of Methyl 3-Phenylpyridine-4-Carboxylate (CAS No. 850162-87-7): Properties, Applications, and Industry Insights

Methyl 3-phenylpyridine-4-carboxylate (CAS No. 850162-87-7) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique structural features. This ester derivative combines a pyridine core with a phenyl substituent and a carboxylate group, making it a versatile intermediate for synthesizing bioactive molecules. Its molecular formula C13H11NO2 and precise chemical structure have been characterized through advanced analytical techniques like NMR and mass spectrometry, ensuring high purity for research applications.

Recent trends in drug discovery highlight the growing demand for heterocyclic compounds like methyl 3-phenylpyridine-4-carboxylate. Researchers are exploring its potential as a building block for kinase inhibitors and anti-inflammatory agents, aligning with the surge in interest around targeted therapies. The compound's lipophilicity and hydrogen bonding capacity make it particularly valuable in optimizing drug-like properties, a hot topic in medicinal chemistry forums and AI-driven molecular design platforms.

From a synthetic chemistry perspective, CAS 850162-87-7 demonstrates remarkable stability under standard laboratory conditions, with a melting point range of 98-102°C and solubility profiles favoring polar organic solvents. These characteristics have spurred innovations in green chemistry applications, where scientists are developing more sustainable esterification protocols. The compound's structure-activity relationships (SAR) are frequently discussed in computational chemistry circles, especially regarding molecular docking simulations for novel therapeutic targets.

Industrial applications of methyl 3-phenylpyridine-4-carboxylate extend beyond pharmaceuticals. The flavor and fragrance industry has investigated its derivatives for unique organoleptic properties, while material scientists examine its potential in coordination chemistry for advanced polymers. This multidisciplinary relevance addresses common search queries about multi-functional chemicals and high-value intermediates in specialty chemical markets.

Quality control protocols for 850162-87-7 typically involve HPLC purity verification (>98%) and rigorous spectroscopic characterization. The compound's shelf life and storage requirements (recommended at 2-8°C under inert atmosphere) are frequently asked about in laboratory management forums. Recent publications have optimized large-scale synthesis methods, reducing production costs while maintaining GMP compliance—a critical consideration for contract manufacturing organizations (CMOs).

Emerging research directions include exploring the photophysical properties of methyl 3-phenylpyridine-4-carboxylate derivatives for OLED applications, responding to growing interest in organic electronics. Patent analyses reveal increasing IP activity around modified versions of this compound, particularly for central nervous system (CNS) drug candidates. These developments position CAS 850162-87-7 as a compound of significant commercial and scientific interest in 2024.

Environmental and safety assessments confirm that methyl 3-phenylpyridine-4-carboxylate presents low ecotoxicity, making it suitable for sustainable chemistry initiatives. This aligns with current industry focus on green synthetic routes and benign-by-design principles. The compound's biodegradation pathways are actively studied, addressing regulatory concerns about persistent organic pollutants (POPs) in chemical manufacturing.

For researchers sourcing this material, technical specifications often emphasize the importance of isomeric purity and residual solvent content. Leading suppliers now provide detailed technical data sheets (TDS) with batch-specific chromatograms, responding to quality assurance demands in preclinical research. The global market for such fine chemicals is projected to grow at 6.2% CAGR through 2030, driven by expanding biopharmaceutical pipelines and custom synthesis requirements.

Recommended suppliers
煙臺(tái)朗裕新材料科技有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shanghai Aoguang Biotechnology Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Aoguang Biotechnology Co., Ltd
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen Jianxing Pharmaceutical Technology Co., Ltd.
Suzhou Senfeida Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Suzhou Senfeida Chemical Co., Ltd
Nanjing Jubai Biopharm
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing Jubai Biopharm